Back to Search
Start Over
Glycoprotein IbĪ± inhibitor (CCP-224) prevents neutrophil-platelet aggregation in sickle cell disease
- Publication Year :
- 2017
- Publisher :
- American Society of Hematology, 2017.
-
Abstract
- Key Points CCP-224 attenuates neutrophil-platelet aggregation in SCD patient blood. CCP-224 has the potential to prevent vaso-occlusion in SCD patients.
- Subjects :
- 0301 basic medicine
chemistry.chemical_classification
musculoskeletal diseases
congenital, hereditary, and neonatal diseases and abnormalities
Platelet aggregation
business.industry
Cell
Hematology
Disease
Stimulus Report
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
medicine.anatomical_structure
chemistry
immune system diseases
hemic and lymphatic diseases
Immunology
medicine
Platelet
Glycoprotein
business
skin and connective tissue diseases
030215 immunology
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....c64507ceb6949d185be560512c2958f6